5 Results for "

PA14

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "PA14" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-128780B
CAS No.: 2408422-41-1
Purity:  99.74%
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

SPR206 acetate is a polymyxin analog with antibiotic activity against Gram-negative pathogens, including multidrug-resistant (MDR) variants. SPR206 acetate has an anti-bacterial infection effect by interacting with the bacterium’s outer membrane. The MIC values of SPR206 acetate against Pseudomonas aeruginosa Pa14 and Acinetobacter baumannii NCTC13301 are both 0.125 mg/L .
loading...
    loading...
Cat. No.: HY-W040185
CAS No.: 80724-31-8
Synonyms: 1,2-DPPA sodium; PA(14:0/14:0) sodium; 1,2-Dimyristoyl-sn-glycero-3-phosphate sodium
Target:  

Liposome

Research Areas:  

Metabolic Disease

1,2-Dimyristoyl-sn-glycero-3-phosphate monosodium is a phospholipid containing the long-chain (14:0) myristic acid inserted at the sn-1 and sn-2 positions. It can be used in the generation of micelles, liposomes, and other types of artificial membranes.
loading...
    loading...
Cat. No.: HY-128780
CAS No.: 2407717-17-1
Synonyms: SPR206
Target:  

Bacterial

Research Areas:  

Infection Cancer

Upleganan (SPR206), a polymyxin analogue, and shows antibiotic activity against multidrug resistant Gram-negative pathogen. The MIC values of Upleganan against Pseudomonas aeruginosa Pa14 and Acinetobacter baumannii NCTC13301 are both 0.125 mg/L .
loading...
    loading...
Cat. No.: HY-173270
Target:  

Bacterial

Research Areas:  

Infection

Antibacterial synergist 3 is a dual-acting inhibitor of biofilm (IC50 of PAO1: 0.40 μM and IC50 of PA14: 1.45 μM). Antibacterial synergist 3 reduces virulence production by inhibiting the quorum sensing (QS) system and induces iron deficiency in P. aeruginosa PAO1. Antibacterial synergist 3 enhances the efficacy of Tobramycin (HY-B0441) and Ciprofloxacin (HY-B0356) in a mouse wound infection model. Antibacterial synergist 3 can be used for the research of P. aeruginosa infections .
loading...
    loading...
Cat. No.: HY-180115
Target:  

Bacterial MMP

Research Areas:  

Infection

LP07 is an antibacterial agent targeting Pseudomonas aeruginosa with MIC values for both wild-type and efflux pump-deficient P. aeruginosa PA14 of both 8 μg/mL. LP07 exerts its antibacterial effect by directly disrupting the structural integrity of the bacterial cell membrane. LP07 moderately inhibits MMP-17 and MMP-19, but has no significant inhibitory effect on other MMP subtypes. LP07 does not inhibit the activity of LpxC enzyme. LP07 can be used for research on Pseudomonas aeruginosa infections .
loading...
    loading...